105 related articles for article (PubMed ID: 11532001)
21. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
Saville MK; Watson RJ
Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation.
Xu X; Nakano T; Wick S; Dubay M; Brizuela L
Biochemistry; 1999 Jul; 38(27):8713-22. PubMed ID: 10393546
[TBL] [Abstract][Full Text] [Related]
23. Structural studies on phospho-CDK2/cyclin A bound to nitrate, a transition state analogue: implications for the protein kinase mechanism.
Cook A; Lowe ED; Chrysina ED; Skamnaki VT; Oikonomakos NG; Johnson LN
Biochemistry; 2002 Jun; 41(23):7301-11. PubMed ID: 12044161
[TBL] [Abstract][Full Text] [Related]
24. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.
Song H; Hanlon N; Brown NR; Noble ME; Johnson LN; Barford D
Mol Cell; 2001 Mar; 7(3):615-26. PubMed ID: 11463386
[TBL] [Abstract][Full Text] [Related]
25. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
[TBL] [Abstract][Full Text] [Related]
26. [Identification of new substrates of cyclin-activated kinases in breast cancers].
Lilischkis R; Barczak E; Marwedel M; Mehraein Y; Lauterlein M; Lüscher B; Kreipe H
Verh Dtsch Ges Pathol; 2001; 85():269-74. PubMed ID: 11894409
[TBL] [Abstract][Full Text] [Related]
27. Kinetic basis for activation of CDK2/cyclin A by phosphorylation.
Hagopian JC; Kirtley MP; Stevenson LM; Gergis RM; Russo AA; Pavletich NP; Parsons SM; Lew J
J Biol Chem; 2001 Jan; 276(1):275-80. PubMed ID: 11029468
[TBL] [Abstract][Full Text] [Related]
28. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
29. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
30. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
[TBL] [Abstract][Full Text] [Related]
31. Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase.
Chiariello M; Gomez E; Gutkind JS
Biochem J; 2000 Aug; 349 Pt 3(Pt 3):869-76. PubMed ID: 10903150
[TBL] [Abstract][Full Text] [Related]
32. Use of an oriented peptide library to determine the optimal substrates of protein kinases.
Songyang Z; Blechner S; Hoagland N; Hoekstra MF; Piwnica-Worms H; Cantley LC
Curr Biol; 1994 Nov; 4(11):973-82. PubMed ID: 7874496
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.
Connell-Crowley L; Solomon MJ; Wei N; Harper JW
Mol Biol Cell; 1993 Jan; 4(1):79-92. PubMed ID: 8443411
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex.
Rogatsky I; Trowbridge JM; Garabedian MJ
J Biol Chem; 1999 Aug; 274(32):22296-302. PubMed ID: 10428798
[TBL] [Abstract][Full Text] [Related]
35. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
Luciani MG; Hutchins JR; Zheleva D; Hupp TR
J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
Petersen BO; Lukas J; Sørensen CS; Bartek J; Helin K
EMBO J; 1999 Jan; 18(2):396-410. PubMed ID: 9889196
[TBL] [Abstract][Full Text] [Related]
37. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
[TBL] [Abstract][Full Text] [Related]
38. DP1 phosphorylation in multimeric complexes: weaker interaction with cyclin A through the E2F1 cyclin A binding domain leads to more efficient phosphorylation than stronger interaction through the p107 cyclin A binding domain.
Guida P; Zhu L
Biochem Biophys Res Commun; 1999 May; 258(3):596-604. PubMed ID: 10329431
[TBL] [Abstract][Full Text] [Related]
39. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.
Zhao J; Dynlacht B; Imai T; Hori T; Harlow E
Genes Dev; 1998 Feb; 12(4):456-61. PubMed ID: 9472014
[TBL] [Abstract][Full Text] [Related]
40. Autocatalytic phosphorylation of CDK2 at the activating Thr160.
Abbas T; Jha S; Sherman NE; Dutta A
Cell Cycle; 2007 Apr; 6(7):843-52. PubMed ID: 17361108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
